CEPI’s August 2026 policy report, Realising the 100 Days Mission, reinforces that the 100 Days Mission is not only about speed but about safe, secure vaccine development and response, building on CEPI’s 2025–2026 biosecurity strategy and implementation plan. CEPI’s broader 100 Days Mission framework targets safe, effective, accessible vaccines within 100 days of identifying a pandemic threat, and CEPI has said it needs US$3.6 billion total for its new strategy, with US$1.1 billion already secured and US$2.5 billion still sought.
The technical implication is clear: fast biomedical capability without biosafety is a systems hazard. CEPI’s biosecurity priorities explicitly span the full R&D pipeline, including risk identification and mitigation, oversight, sample collection and storage, emergency response planning, nucleic acid synthesis procurement, and monitoring for viruses with enhanced epidemic or pandemic potential; that same logic applies to any high-density lunar bio-lab or biotech preservation facility where one containment failure could become an existential event.
Ark action: treat this report as a design requirement for Lunar Ark biosecurity architecture. Monitor CEPI’s operational standards for biosafety-by-design, emergency response planning, sample-chain integrity, and governance of high-risk research; integrate these into lunar laboratory containment, specimen archiving, crew health protocols, and any future off-world vaccine or synthetic biology capability before expansion, not after.
The single most important takeaway is that speed is only civilization-preserving when biosafety is embedded end-to-end, because a 100-day response system that leaks pathogens is a civilizational liability rather than a defense.